Integrated Filing — IndAS



General information about company

Scrip Code 544497
NSE Symbol AHCL
MSEI Symbol NOTLISTED
ISIN INE0Y8W01025
Name of company ANLON HEALTHCARE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 30-07-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 27-07-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Single segment
Description of single segment Manufacturing & Sale of Active Pharmaceutical Ingredients
Start date and time of board meeting 30-07-2026   10:30:00
End date and time of board meeting 30-07-2026   11:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No such default was made.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 3,097.56 3,097.56
Other income 5.96 5.96
Total income 3,103.52 3,103.52
2 Expenses
(a) Cost of materials consumed 2,694.05 2,694.05
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (789.16) (789.16)
(d) Employee benefit expense 152.07 152.07
(e) Finance costs 96.36 96.36
(f) Depreciation, depletion and amortisation expense 65.79 65.79
(f) Other Expenses
1 Others 294.04 294.04
Total other expenses 294.04 294.04
Total expenses 2,513.15 2,513.15
3 Total profit before exceptional items and tax 590.37 590.37
4 Exceptional items 0.00 0.00
5 Total profit before tax 590.37 590.37
6 Tax expense
7 Current tax 152.39 152.39
8 Deferred tax (41.73) (41.73)
9 Total tax expenses 110.66 110.66
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 479.71 479.71
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 479.71 479.71
17 Other comprehensive income net of taxes (1.73) (1.73)
18 Total Comprehensive Income for the period 477.98 477.98
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 10,630.30 10,630.30
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.09 0.09
Diluted earnings (loss) per share from continuing operations 0.09 0.09
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.09 0.09
Diluted earnings (loss) per share from continuing and discontinued operations 0.09 0.09
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026 01-04-2026
Date of end of reporting period 30-06-2026 30-06-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Amount which will not be reclassified to P & L (2.31) (2.31)
Total Amount of items that will not be reclassified to profit and loss (2.31)
2 Income tax relating to items that will not be reclassified to profit or loss (0.58) (0.58)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (1.73) (1.73)





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 01-09-2025
Amount Raised 12,103.00
Report filed for Quarter ended 30-06-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable Crisil Ratings Limited
Is there a Deviation / Variation in use of funds raised Yes
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders Yes
If Yes, Date of shareholder Approval 07-01-2026
Explanation for the Deviation / Variation Company proposed to vary the object in relation to the capital expenditure and proposed expansion and proposes to deploy/ utilize an amount of Rs. 2,332.69 lakhs out of Rs. 3,071.95 lakhs for such strategic acquisitions/ mergers/ buy-outs to grow inorganically, and further upgradation of the manufacturing facilities
Comments of the Audit Committee after review No Comment
Comments of the auditors, if any No Comment
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Funding capital expenditure requirements for the expansion of our Manufacturing Facility As per explanation provided above 3,071.95 0.00 3,071.95 0.00
2 Full or part repayment and/or pre-payment of certain outstanding secured borrowing (term loan) availed by our Company Not Applicable 500.00 0.00 500.00 0.00
3 Funding the Working capital requirement Not Applicable 4,315.00 0.00 4,315.00 0.00
4 Offer Expense Not Applicable 1,513.05 1,428.66 1,428.66 0.00
5 General Corporate Purpose Not Applicable 2,703.00 2,787.39 2,787.39 0.00


Signatory Details

Name of signatory PUNITKUMAR RASADIA
Designation of person Managing Director
Place Rajkot
Date 30-07-2026